MYL9 and colorectal carcinoma: We discovered that MYL9 was a downstream target substrate of PRPF19, owing to that PRPF19 stabilized MYL9 by K63-linked ubiquitination, and demonstrated that PRPF19 exerted its pro-metastasis effects in CRC in an MYL9-mediated manner.